1. Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor‑positive/progesterone receptor‑negative breast cancer
   Helena Fohlin et al, 2020, Molecular and Clinical Oncology CrossRef
2. Salivary DNA methylation markers for cancer of oral cavity
   Shama Prasada Kabekkodu et al, 2022, Cancer Biomarkers CrossRef
3. RAB6C is an independent prognostic factor of estrogen receptor‑positive/progesterone receptor‑negative breast cancer
   Helena Fohlin et al, 2019, Oncology Letters CrossRef